Novartis AG Total Long Term Liabilities 2012-2026 | NVS

Novartis AG total long term liabilities for the quarter ending March 31, 2026 were $48.231B, a 61.47% increase year-over-year.

  • Novartis AG total long term liabilities for 2025 were $37.122B, a 26.15% increase from 2024.
  • Novartis AG total long term liabilities for 2024 were $29.428B, a 9.79% increase from 2023.
  • Novartis AG total long term liabilities for 2023 were $26.805B, a 8.75% decline from 2022.

Novartis AG Total Long Term Liabilities 2012-2026 | NVS

  • Novartis AG total long term liabilities for 2025 were $37.122B, a 26.15% increase from 2024.
  • Novartis AG total long term liabilities for 2024 were $29.428B, a 9.79% increase from 2023.
  • Novartis AG total long term liabilities for 2023 were $26.805B, a 8.75% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B